Skip to content
10-Q/A

Quarterly Report

iBio, Inc. IBIO

0001420720-25-000043

← back to feed
Filed
Nov 17, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Nov 10, 2025 22.49M sh
Shares Diluted Q1 2026 · Sep 30, 2025 52.98M sh
Shares Diluted Q1 2026 · Sep 30, 2024 8.63M sh
Capex Q1 2026 · Sep 30, 2025 $32K
Capex Q1 2026 · Sep 30, 2024 $0
Operating Cash Flow Q1 2026 · Sep 30, 2025 −$5.67M
Operating Cash Flow Q1 2026 · Sep 30, 2024 −$3.72M
Cash And Equivalents Q1 2026 · Sep 30, 2025 $28.11M
Cash And Equivalents Q1 2026 · Jun 30, 2025 $8.58M
Stockholders Equity Q1 2026 · Sep 30, 2025 $56.04M
Stockholders Equity Q1 2026 · Jun 30, 2025 $14.88M
Current Liabilities Q1 2026 · Sep 30, 2025 $6.05M
Current Liabilities Q1 2026 · Jun 30, 2025 $6.11M
Total Liabilities Q1 2026 · Sep 30, 2025 $8.12M
Total Liabilities Q1 2026 · Jun 30, 2025 $8.31M
Current Assets Q1 2026 · Sep 30, 2025 $50.77M
Current Assets Q1 2026 · Jun 30, 2025 $9.72M
Total Assets Q1 2026 · Sep 30, 2025 $64.16M
Total Assets Q1 2026 · Jun 30, 2025 $23.19M
Eps Diluted Q1 2026 · Sep 30, 2025 −$0.11
Eps Diluted Q1 2026 · Sep 30, 2024 −$0.46
Eps Basic Q1 2026 · Sep 30, 2025 −$0.11
Eps Basic Q1 2026 · Sep 30, 2024 −$0.46
Sga Expense Q1 2026 · Sep 30, 2025 $2.5M
Sga Expense Q1 2026 · Sep 30, 2024 $2.8M
Rd Expense Q1 2026 · Sep 30, 2025 $3.55M
Rd Expense Q1 2026 · Sep 30, 2024 $1.31M
Net Income Q1 2026 · Sep 30, 2025 −$5.72M
Net Income Q1 2026 · Sep 30, 2024 −$3.99M
Operating Income Q1 2026 · Sep 30, 2025 −$5.95M
Operating Income Q1 2026 · Sep 30, 2024 −$4.11M
Revenue Q1 2026 · Sep 30, 2025 $100K
Revenue Q1 2026 · Sep 30, 2024 $0